Advances in Ocular Immunology of Diabetes and Related Complications: Mechanisms and Treatments
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 30 April 2024 | Viewed by 348
Special Issue Editor
Interests: ocular therapeutics; corneal neuropathy; dry eye disease; meibomian gland dysfunction; anterior segment morphology; corneal immunology; ocular surface neurobiology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Corneal neuroimmune features have become a focal point in the study of diabetic neuropathy. In fact, corneal neuroimmune features measured with corneal confocal microscopy are considered a biomarker for diabetic peripheral neuropathy. Previous research conducted on diabetic chronic kidney disease indicated that it leads to more severe corneal neuroinflammation and greater corneal nerve loss. Certain treatments suggesting the potential regeneration of corneal nerves or amelioration of associated neuroinflammation in diabetes and its complications were explored. However, there are still many unanswered questions in this expanding area of ophthalmic research, necessitating further research. This issue will focus on the mechanisms and treatment of corneal neuroimmune abnormalities in metabolic diseases such as type 1 diabetes, diabetic chronic kidney disease, type 2 diabetes, metabolic syndrome and prediabetes. The issue will also cover the impact of diabetic and non-diabetic medications on corneal neuroimmune features in impaired glycemia. Papers exploring ocular surface and retinal inflammation in diabetes and related complications are also encouraged. This issue will be a collection of original papers and reviews.
Dr. Kofi Asiedu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- corneal neuropathy
- diabetic keratopathy
- neuroimmune features
- neurotrophic keratitis
- dry eye disease in diabetes
- corneal neuroinflammation
- ocular surface disease
- diabetic retinopathy
